RAPID SURVEY OF COVID-19 VACCINE PRIORITISATION
We are collecting information on vaccines prioritisation policies. Join us in collecting data across countries.
COVID-19, older people and non-communicable diseases
On Friday, 29 January, 2pm UK time
A B Dey, Professor & Head Department of Geriatric Medicine All India Institute of Medical Sciences New Delhi.
Caring older people in LMICs during COVID 19 pandemic and the double burden of NCDs- lessons learnt.
Max Bachmann, Professor of Health Services Research, University of East Anglia.
NCDs and COVID-19 and older people: evidence from South Africa.
Further speakers to be confirmed.
CALL FOR WEEKLY WEBINAR PROPOSALS
The weekly webinars have been a big success. We want to build on this by offering network members the opportunity to organise webinar sessions.
The Platform will facilitate this process by:
Managing proposals and timeslots.
Promoting on our site, in our newsletter and via social media.
Posting slides and recordings after the event (if you wish).
Posting related blogs and material.
COVID-19 vaccine prioritisation in low and middle-income countries: where should older people fit in?
Concern about vaccine nationalism is important and well-founded, but it has overshadowed another key form of injustice: vaccine ageism.
Brazil gained prominence in the pandemic, occupying 2nd place in the global ranking of infections and deaths. Considering the risk factors among older people, the ELSI-COVID-19 initiative arose as a strategy to understand the effects of the pandemic in the lives of older adults.
How does age fit and intersect with other issues and identities? How can we encourage more inclusive, joined-up thinking?
A rápida mudança da pirâmide etária populacional brasileira, com o progressivo estreitamento da base e alargamento do topo, caracteriza a transição demográfica, cujo padrão se assemelha a vários países de baixa e média renda.
As the world starts to vaccinate, a lot of questions have started to appear in the media about the characteristics and reliability of different jabs. To better understand the challenges of mass immunisation in the context of low and middle income countries (LMICs), we have contacted Dr Anderson Brito, a virologist with experience in the Brazilian context.
SUBSCRIBE TO OUR MAILING LIST HERE